SCHEMBL4269356

SCHEMBL4269356

Cc1ccc(C=Cc2ccc3c(c2)NC(=O)CO3)c(C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.64
NR3C2 P08235 2/20 0.64
PARP1 P09874 1/20 0.47
PKM P14618 3/20 0.46
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 3/20 0.44
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
THRB P10828 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13932049 1.00 MMP12 (0.64) MMP12NR3C2PARP1PKMPOLB
SCHEMBL4258337 0.88 NR3C2 (0.61) MMP12NR3C2PARP1PKMPOLB
SCHEMBL4262882 0.88 NR3C2 (0.61) MMP12NR3C2PARP1PKMGAA
SCHEMBL13932112 0.88 NR3C2 (0.61) MMP12NR3C2PARP1PKMPOLB
SCHEMBL13932240 0.88 NR3C2 (0.61) MMP12NR3C2PARP1PKMGAA
SCHEMBL13932042 0.88 NR3C2 (0.63) MMP12NR3C2PARP1PKMTP53
SCHEMBL4266691 0.88 NR3C2 (0.63) MMP12NR3C2PARP1PKMTP53
SCHEMBL13932100 0.86 NR3C2 (0.68) MMP12NR3C2PARP1PKMPOLB
SCHEMBL4267625 0.86 NR3C2 (0.68) MMP12NR3C2PARP1PKMPOLB
SCHEMBL13932103 0.84 NR3C2 (0.57) MMP12NR3C2PKMPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2009-02-26 US claimed
JP-2008508314-A 2008-03-21 JP claimed
EP-1778242-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2007-05-02 EP claimed
WO-2006015259-A2 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS IRM LLC (BM) 2006-02-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054417-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS NR5A1, ESRRA, NR3C1 MMP12 2999/4885NR3C2 7/4885PARP1 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.